Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 6,800 shares at $11.41 ($78K) on 2019-03-07, disclosed to the SEC on 2019-03-08.
Seasonal sale ($78k) by Chief Executive Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |